Latest TGTX reports update at 2024-05-06: 2024-Q12023-Q42023-Q1
TG Therapeutics logo
TG Therapeutics TGTX
$ 16.3 -3.49%

TG Therapeutics Operating Expenses 2011-2024 | TGTX

Annual Operating Expenses TG Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - 274 M 169 M 175 M 119 M 79.1 M 63.3 M 55.9 M 20.3 M 25.8 M 882 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
274 M 882 K 98.2 M

Quarterly Operating Expenses TG Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - 60.7 M 44.8 M - 35.1 M 39.5 M 68.9 M - 87.2 M 79 M 90 M - 85.8 M 50.9 M 50.3 M 38 M 60.9 M 35.6 M 34.7 M 54.2 M 34.4 M 44.4 M 41.6 M 31.1 M 31.6 M 28.5 M 27.7 M 24.1 M 25 M 16.1 M 14 M 17.7 M 13.9 M 17.1 M 14.6 M 18.8 M 17.5 M 12 M 7.64 M - 4.69 M 6.67 M 3.75 M - 2.71 M 3.1 M 17.4 M - 30.1 K 297 K -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
90 M 30.1 K 32.4 M